Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.

Sharples CG, Kaiser S, Soliakov L, Marks MJ, Collins AC, Washburn M, Wright E, Spencer JA, Gallagher T, Whiteaker P, Wonnacott S.

J Neurosci. 2000 Apr 15;20(8):2783-91.

2.

The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC, Marks MJ.

Biochem Pharmacol. 2007 Oct 15;74(8):1235-46. Epub 2007 Jul 27. Review.

3.

Nicotinic receptor antagonists as treatments for nicotine abuse.

Crooks PA, Bardo MT, Dwoskin LP.

Adv Pharmacol. 2014;69:513-51. doi: 10.1016/B978-0-12-420118-7.00013-5. Review.

4.

Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.

Yang KC, Jin GZ, Wu J.

Acta Pharmacol Sin. 2009 Jun;30(6):740-51. doi: 10.1038/aps.2009.63. Review.

5.

Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy.

Quik M, McIntosh JM.

J Pharmacol Exp Ther. 2006 Feb;316(2):481-9. Epub 2005 Oct 6. Review.

6.

Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands.

Astles PC, Baker SR, Boot JR, Broad LM, Dell CP, Keenan M.

Curr Drug Targets CNS Neurol Disord. 2002 Aug;1(4):337-48. Review.

PMID:
12769608
7.

Desensitization of nicotinic acetylcholine receptors as a strategy for drug development.

Buccafusco JJ, Beach JW, Terry AV Jr.

J Pharmacol Exp Ther. 2009 Feb;328(2):364-70. doi: 10.1124/jpet.108.145292. Epub 2008 Nov 20. Review.

8.

Epibatidine structure-activity relationships.

Carroll FI.

Bioorg Med Chem Lett. 2004 Apr 19;14(8):1889-96. Review. Erratum in: Bioorg Med Chem Lett. 2004 Nov 15;14(22):5713.

PMID:
15050621
9.

Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics.

Decker MW, Meyer MD.

Biochem Pharmacol. 1999 Sep 15;58(6):917-23. Review.

PMID:
10509744
10.

Residues Responsible for the Selectivity of α-Conotoxins for Ac-AChBP or nAChRs.

Lin B, Xiang S, Li M.

Mar Drugs. 2016 Oct 11;14(10). pii: E173. Review.

11.

Characterization of [(3)H]epibatidine binding to nicotinic receptors from bovine adrenal medulla.

McKay DB, Free RB, Kaser DJ, McKay SB.

Ann N Y Acad Sci. 2002 Oct;971:162-4. Review. No abstract available.

PMID:
12438112
12.

Nicotinic acetylcholine receptors: an overview on drug discovery.

D'hoedt D, Bertrand D.

Expert Opin Ther Targets. 2009 Apr;13(4):395-411. doi: 10.1517/14728220902841045 . Review.

PMID:
19335063
13.

α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.

Cuny H, Yu R, Tae HS, Kompella SN, Adams DJ.

Br J Pharmacol. 2017 May 6. doi: 10.1111/bph.13852. [Epub ahead of print] Review.

PMID:
28477355
14.

Epibatidine: impact on nicotinic receptor research.

Dukat M, Glennon RA.

Cell Mol Neurobiol. 2003 Jun;23(3):365-78. Review.

PMID:
12825833
15.

Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain.

Sihver W, Långström B, Nordberg A.

Acta Neurol Scand Suppl. 2000;176:27-33. Review.

PMID:
11261802
16.

Granulocytes as models for human protein marker identification following nicotine exposure.

Mulcahy MJ, Lester HA.

J Neurochem. 2017 Aug;142 Suppl 2:151-161. doi: 10.1111/jnc.14010. Review.

PMID:
28791704
17.

Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission.

Exley R, Cragg SJ.

Br J Pharmacol. 2008 Mar;153 Suppl 1:S283-97. Epub 2007 Nov 26. Review.

18.

Alpha9 nicotinic acetylcholine receptors and the treatment of pain.

McIntosh JM, Absalom N, Chebib M, Elgoyhen AB, Vincler M.

Biochem Pharmacol. 2009 Oct 1;78(7):693-702. doi: 10.1016/j.bcp.2009.05.020. Epub 2009 May 27. Review.

19.

Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms.

Dutertre S, Nicke A, Tsetlin VI.

Neuropharmacology. 2017 Jun 13. pii: S0028-3908(17)30281-2. doi: 10.1016/j.neuropharm.2017.06.011. [Epub ahead of print] Review.

PMID:
28623170
20.

Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.

Hone AJ, McIntosh JM.

FEBS Lett. 2017 Oct 14. doi: 10.1002/1873-3468.12884. [Epub ahead of print] Review.

PMID:
29030971

Supplemental Content

Support Center